Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Provided By GlobeNewswire
Last update: Jan 27, 2025
JERUSALEM, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced that it will participate and be available for investor meetings at the Oppenheimer 35th Annual Healthcare Life Sciences Conference being held February 11 – 12, 2025 in a virtual format.
Read more at globenewswire.com
